Custom Search

Thursday, December 7, 2017

Monoclinal Antibidies found to be reducing occurance of migrane

There is very little treatment options available for migraine and often those are not so effective in all patients unlike like other disease treatment involves lot of change overs in medications. A protein called calcitonin gene–related peptide (CGRP)is responsible for migraine. Hence to prevent the occurnce of migrane monoclonal antibodies which target this peptide was studied and found that
Monoclonal antibody Fremanezumab when given once in month have reduced the occurnce of migrane attacks to about 50% compared with patients not treated with Fremanezumab.
It could be best option for treatment in combination with existing therapy available for migraine.

Migraine is very sever form of headache,  people suffering with migraine have very limited option for treatment, moreover the treatment always are not successful in bringing down the occurnce of migrane pain attack.

Person suffering with migraine experience aura or zigzag lights, with sever pain.
Treatment involves drugs, non steroidal anti inflammatory agents like Ibuprofen, aspirin metoclopramide and opoind analgesics are used.
Some medicines like haloperidol and valporates are also used to treat depending up on the severity.

Posted by: Martin

How to sucessfuly activate and receive our articles on pharmaceuticals by E-Mail

Dear readers if you wish to receive our articles on pharmaceutical automatically into your email Inbox , as and when we write a new article over this website, then follow these 3 simple steps.


1.You should write your Email ID in the box provided and push the subscribe butten


2.Enter the text code that we show you in a small new browser window after you enter your email ID.

3.Log in to your email and Cheke our verification email sent by "FEEDBURNER" , there you should verify the link we send you by email.




Enter your email address get our articles by email whenever this website is updated





Delivered by FeedBurner



Join the list of our readers from Universities ,Research and Development centers Pharmaceutical Companies from all over the world.











Pharma Research Regulatory Guidelines Website
Texas Dallas, TX 75211 US
Email: editor@pharmacistspharmajournal.org Website: http://pharmacistspharmajournal.org/
Copyright © 2008-2015 all rights reserve www.pharmacistspharmajournal.org